India’s Covaxin Found To Offer 77.8 Percent Protection Against COVID-19: Study
GENEVA, Nov 12 — Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8 per cent protection against COVID-19, according…